Neurocrine Biosciences, Inc. (NBIX), based in San Diego, California, is a leading biopharmaceutical company specializing in the development of innovative treatments for neurological, endocrine, and psychiatric disorders. The company boasts a robust pipeline, including advanced therapies targeting Parkinson's disease, epilepsy, and various other serious medical conditions, addressing critical unmet needs in patient care. Neurocrine's commitment to scientific excellence and strategic partnerships positions it for significant growth and continued contributions to the biopharmaceutical landscape, enhancing outcomes for patients worldwide.